1. Home
  2. TRX vs TLSA Comparison

TRX vs TLSA Comparison

Compare TRX & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TRX Gold Corporation

TRX

TRX Gold Corporation

HOLD

Current Price

$1.29

Market Cap

470.0M

Sector

N/A

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.26

Market Cap

155.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRX
TLSA
Founded
1990
2013
Country
Canada
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
470.0M
155.2M
IPO Year
2002
2017

Fundamental Metrics

Financial Performance
Metric
TRX
TLSA
Price
$1.29
$1.26
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$1.70
N/A
AVG Volume (30 Days)
4.4M
125.2K
Earning Date
04-13-2026
05-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$73.52
N/A
Revenue Next Year
$109.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.73
52 Week High
$2.80
$2.60

Technical Indicators

Market Signals
Indicator
TRX
TLSA
Relative Strength Index (RSI) 38.21 46.09
Support Level $0.32 $1.27
Resistance Level $1.95 $1.59
Average True Range (ATR) 0.10 0.11
MACD -0.05 0.00
Stochastic Oscillator 8.11 36.00

Price Performance

Historical Comparison
TRX
TLSA

About TRX TRX Gold Corporation

TRX Gold Corp is engaged in the exploration, development, and production of mineral property interests in the United Republic of Tanzania, focused on development and mining operations, and on exploring and evaluating its mineral properties. The business of exploring and mining for minerals involves a high degree of risk, and the underlying value of the mineral properties depends on the existence and economic recovery of mineral resources and reserves, as well as the ability to raise long-term financing to continue development. The company is focused on the Buckreef Gold Project, which comprises five prospects: Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba, and includes three main mineralized zones: Buckreef South, Buckreef Main, and Buckreef North.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.

Share on Social Networks: